Indopedia All Things Marijuana
Interest in psychedelics is surging, fueled by growing research suggesting they have a place in treatment of conditions like depression and post-traumatic stress disorder. But regulatory challenges loom.
The nation’s first program to sell psychedelic drugs to the public opened in Oregon in June. Several states are funding clinical trials and considering new laws and regulations that would loosen decades-long restrictions on the drugs’ manufacture and distribution. Those plans may face federal regulations that classify psychedelics as schedule 1 controlled substances, with no therapeutic value.
The Gazette spoke with Mason Marks, a visiting professor at Harvard Law School who leads the School’s Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy,…
